331 related articles for article (PubMed ID: 12115184)
21. Chondrogenesis of expanded adult human articular chondrocytes is enhanced by specific prostaglandins.
Jakob M; Démarteau O; Suetterlin R; Heberer M; Martin I
Rheumatology (Oxford); 2004 Jul; 43(7):852-7. PubMed ID: 15113997
[TBL] [Abstract][Full Text] [Related]
22. N-butyryl glucosamine increases matrix gene expression by chondrocytes.
Poustie MW; Carran J; McEleney K; Dixon SJ; Anastassiades TP; Bernier SM
J Pharmacol Exp Ther; 2004 Nov; 311(2):610-6. PubMed ID: 15240824
[TBL] [Abstract][Full Text] [Related]
23. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
24. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of chondrocyte aggrecan and type-II collagen gene expression correlates with increases in static compression magnitude and duration.
Ragan PM; Badger AM; Cook M; Chin VI; Gowen M; Grodzinsky AJ; Lark MW
J Orthop Res; 1999 Nov; 17(6):836-42. PubMed ID: 10632450
[TBL] [Abstract][Full Text] [Related]
26. Effects of interferon-gamma and tumor necrosis factor alpha on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes.
Dodge GR; Diaz A; Sanz-Rodriguez C; Reginato AM; Jimenez SA
Arthritis Rheum; 1998 Feb; 41(2):274-83. PubMed ID: 9485085
[TBL] [Abstract][Full Text] [Related]
27. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of aggrecan and type II collagen mRNA expression in bovine chondrocytes by the application of hydrostatic pressure.
Toyoda T; Seedhom BB; Kirkham J; Bonass WA
Biorheology; 2003; 40(1-3):79-85. PubMed ID: 12454390
[TBL] [Abstract][Full Text] [Related]
29. Control of human articular chondrocyte differentiation by reduced oxygen tension.
Murphy CL; Polak JM
J Cell Physiol; 2004 Jun; 199(3):451-9. PubMed ID: 15095292
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis.
Appleton CT; Usmani SE; Bernier SM; Aigner T; Beier F
Arthritis Rheum; 2007 Nov; 56(11):3693-705. PubMed ID: 17968906
[TBL] [Abstract][Full Text] [Related]
31. Differential responses of chondrocytes from normal and osteoarthritic human articular cartilage to mechanical stimulation.
Salter DM; Millward-Sadler SJ; Nuki G; Wright MO
Biorheology; 2002; 39(1-2):97-108. PubMed ID: 12082272
[TBL] [Abstract][Full Text] [Related]
32. Alterations in expression of cartilage-specific genes for aggrecan and collagen type II in osteoarthritis.
Jalbă BA; Jalbă CS; Vlădoi AD; Gherghina F; Stefan E; Cruce M
Rom J Morphol Embryol; 2011; 52(2):587-91. PubMed ID: 21655647
[TBL] [Abstract][Full Text] [Related]
33. Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis.
Matyas JR; Adams ME; Huang D; Sandell LJ
Arthritis Rheum; 1995 Mar; 38(3):420-5. PubMed ID: 7533495
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats.
Chang JK; Chang LH; Hung SH; Wu SC; Lee HY; Lin YS; Chen CH; Fu YC; Wang GJ; Ho ML
Arthritis Rheum; 2009 Oct; 60(10):3049-60. PubMed ID: 19790062
[TBL] [Abstract][Full Text] [Related]
35. Intermittent hydrostatic pressure inhibits shear stress-induced nitric oxide release in human osteoarthritic chondrocytes in vitro.
Lee MS; Trindade MC; Ikenoue T; Schurman DJ; Goodman SB; Smith RL
J Rheumatol; 2003 Feb; 30(2):326-8. PubMed ID: 12563690
[TBL] [Abstract][Full Text] [Related]
36. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.
Kim DJ; Moon SH; Kim H; Kwon UH; Park MS; Han KJ; Hahn SB; Lee HM
Spine (Phila Pa 1976); 2003 Dec; 28(24):2679-84. PubMed ID: 14673369
[TBL] [Abstract][Full Text] [Related]
37. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
Lohmander LS
J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
[TBL] [Abstract][Full Text] [Related]
38. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid.
Céleste C; Ionescu M; Robin Poole A; Laverty S
J Orthop Res; 2005 May; 23(3):602-10. PubMed ID: 15885481
[TBL] [Abstract][Full Text] [Related]
39. Compressive compared with tensile loading of medial collateral ligament scar in vitro uniquely influences mRNA levels for aggrecan, collagen type II, and collagenase.
Majima T; Marchuk LL; Sciore P; Shrive NG; Frank CB; Hart DA
J Orthop Res; 2000 Jul; 18(4):524-31. PubMed ID: 11052487
[TBL] [Abstract][Full Text] [Related]
40. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
Ratcliffe A; Beauvais PJ; Saed-Nejad F
J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
